Eye Health News and Research

Latest Eye Health News and Research

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.

11 Nov 2009

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced the re-launch of FOCUS (http://www.vyvanseFOCUS.com), a free, online patient support program for adults taking once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), and the only online, branded personalized patient support program providing tips and tools for adults diagnosed with ADHD taking a prescription medication.

11 Nov 2009

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses.

11 Nov 2009

Glissandra Skincare launches three signature anti-aging products

Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund’s “Women of Action” awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.

11 Nov 2009

Global Health partners with Eira Hospital to start obesity treatment operations in Finland

In collaboration with Eira Hospital in Helsinki, Global Health Partner (STO:GHP) has started up obesity treatment operations and the first bariatric surgery procedure has now been performed. Finland has the highest obesity prevalence in the Nordic countries. However, the number of bariatric surgery procedures has so far been very low. “We see Finland as a very exciting market with great potential and are happy to be doing this in collaboration with the well-reputed Eira Hospital,” says Per Båtelson, Global Health Partner’s CEO.

11 Nov 2009

$9M ARRA funds to reduce healthcare-associated infections in ambulatory surgical centers

To reduce healthcare-associated infections (HAIs) in stand-alone or same-day surgical centers, the HHS Secretary Kathleen Sebelius today announced the availability of up to $9 million in funding from the American Recovery and Reinvestment Act (ARRA) to state survey agencies in 43 states. HAIs are infections some patients acquire when they are in a health care setting such as a hospital or outpatient clinic.

11 Nov 2009

Handbook for rural health care ethics

With an eye to small-town health professionals as well as to the people training students to practice medicine beyond metropolitan settings, Dartmouth's Department of Community and Family Medicine is unveiling the Handbook for Rural Health Care Ethics.

11 Nov 2009

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

When a fetus is smaller than expected for the number of weeks of pregnancy, due to associated problems like a poorly developed heart, health concerns as severe as brain damage can result.

11 Nov 2009

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.

11 Nov 2009

Children with autism have slower pupil responses to light change: Study

Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.

11 Nov 2009

Medicare Advantage plans are largely unpopular in rural states

Kansas Health Institute examines Medicare Advantage plans, which are less popular in rural areas, in a series of reports.

11 Nov 2009

Colorcon acquires exclusive rights to market ARmark's micro-tag authentication technology

ARmark Authentication Technologies, LLC, and Colorcon, Inc. announced today an alliance in the development and introduction of ®mark® On-Dose ID(TM), an authentication technology that incorporates microscopic covert micro-tags into the immediate-release film coatings of solid oral dosage forms (SODFs) to prevent counterfeiting.

10 Nov 2009

Goethe University professors discuss cataract surgery and artificial lens implantation

As many as 10 million people around the world suffer from cataracts. Thomas Kohnen of the Goethe University in Frankfurt and his coauthors discuss cataract surgery with the implantation of an artificial lens in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2009; 106[43]: 695).

10 Nov 2009

House-passed abortion restrictions could stir up Senate's health reform debate

The Washington Post: "The abortion issue had been rumbling within the House Democratic caucus for weeks, but Saturday's votes revealed the depths of the fault lines. The amendment passed with the support of 64 Democrats, roughly a quarter of the party caucus." And with an eye on the Senate and eventual conference committee negotiations, abortion-rights supporters are now pledging to strip the amendment out of the underlying health bill.

10 Nov 2009

ISTA Pharmaceuticals presents additional data from its Bepreve Phase 3 clinical studies

ISTA Pharmaceuticals, Inc., today announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies. These results were presented in poster sessions at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Miami Beach, FL.

9 Nov 2009

FDA's approval time for medical devices increases

According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.

7 Nov 2009

Pediatrician recommends red reflex vision test for all newborns

With the number of premature births and medically fragile infants now increasing in the U.S., a basic eye exam, including a red reflex test, should be given to all children shortly after birth, reports Angela Buffenn, M.D., M.P.H., Director of the Orbit and Eye Movement Institute at The Vision Center of Childrens Hospital Los Angeles.

7 Nov 2009

Rituximab drug potentially effective for treating Graves' eye disease, shows study

A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following treatment with the drug rituximab. Inflammation around their eyes and damage to the optic nerve were significantly reduced. The same patients had not previously responded to steroids, a common treatment for Graves' eye disease.

7 Nov 2009

Gonorrhea medication may help fight cancer

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.

6 Nov 2009

Californians who lose jobs find health care safety net badly frayed

In this article for Kaiser Health News, Janet Wilson focuses on California and reports on how the safety net is fraying as economic woes take their toll on state budgets. "With a nip here and a slash there, California's budget crisis is now affecting health care for millions of residents, from wealthy Orange County to the struggling city of Oakland.

6 Nov 2009

Eye Health News and Research

Latest Eye Health News and Research

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Glissandra Skincare launches three signature anti-aging products

Global Health partners with Eira Hospital to start obesity treatment operations in Finland

$9M ARRA funds to reduce healthcare-associated infections in ambulatory surgical centers

Handbook for rural health care ethics

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Children with autism have slower pupil responses to light change: Study

Medicare Advantage plans are largely unpopular in rural states

Colorcon acquires exclusive rights to market ARmark's micro-tag authentication technology

Goethe University professors discuss cataract surgery and artificial lens implantation

House-passed abortion restrictions could stir up Senate's health reform debate

ISTA Pharmaceuticals presents additional data from its Bepreve Phase 3 clinical studies

FDA's approval time for medical devices increases

Pediatrician recommends red reflex vision test for all newborns

Rituximab drug potentially effective for treating Graves' eye disease, shows study

Gonorrhea medication may help fight cancer

Californians who lose jobs find health care safety net badly frayed

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in